NICE issues final and binding yes for Celgene's Vidaza
23 March 2011
Francesca Bruce
Please Login to read the full article.
23 March 2011
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- Patient access scheme prompts NICE U-turn on Novartis' Tasigna, while BMS will appeal against no for Sprycel
- NICE U-turn puts Janssen's Zytiga ahead of Sanofi's Jevtana in prostate cancer
- Novartis trumps Bristol-Myers Squibb at NICE for chronic CML
- IVAN adds to pressure on Lucentis with £85m UK savings claim
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
